Meglinitides Market Analysis and Size
Global Meglinitides Market is expected to witness significant growth during the forecast period. Rising prevalence of type 2 diabetes worldwide and emerging markets are the factors responsible for the growth of this market. Researchers are developing new drugs that are helpful in boosting up the market growth. Many major market players are contributing a lot in drug discovery and development. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global meglinitides market in the forecast period 2022-2029. The expected CAGR of global meglinitides market is tend to be around 3.0% in the mentioned forecast period. The market was valued at USD 3.94 billion in 2021, and it would grow upto USD 5 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Meglinitides are the agents used to treat type 2 diabetes. They act same as β-cell receptor as sulphonylureas, but have a different chemical structure. They are novel class of non-sulfonylurea insulin secretagogues characterized by very rapid onset and abbreviated duration of action. They act by stimulating pancreas to release insulin in response to meal. In functioning pancreatic beta cells, it also closes ATP-dependent potassium dependent channels. Due to this depolarization of beta cells, opening of calcium channels resulting in influx of calcium and Increased intracellular calcium induces insulin secretion. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period.
COVID-19 Impact on Global Meglinitides Market
The Covid-19 pandemic negatively impacted the global meglinitides market because the utmost priority was given to Covid-19 patients for treatment. Diabetes and uncontrolled hyperglycemia are poorly associated with patients having COVID-19, including an increased risk of severe illness or death. Thus, the COVID-19 outbreak increased the meglitinide market's growth globally.
Competitive Landscape and Global Meglinitides Market Share Analysis
Key players operating in the global meglinitides market include:
- Pfizer Inc (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Mylan N.V. (U.S.)
- Fresenius Kabi AG (Germany)
- Hikma Pharmaceuticals PLC (Japan)
- Novartis AG (Switzerland)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Bristol Myers Squibb Company (U.S.)
- GSK Plc. (U.S.)
- Bayer AG (Germany)
- Sun Pharmaceutical Industries Ltd (India)
- Novartis AG (Switzerland)
- Lupin (India)
- Cipla Inc (India)
- Aurobindo Pharma (India)
Access Full Report:-
https://www.databridgemarketresearch.com/reports/global-meglinitides-market
Global Meglinitides Market Regional Analysis/Insights
The global meglinitides market is analysed and market size insights and trends are provided by indication, drugs, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global meglinitides market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Request Access for Sample Report:-
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-meglinitides-market
Major TOC of the Report
1 INTRODUCTION
2 MARKET SEGMENTATION
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
Get TOC of the Report:-
https://www.databridgemarketresearch.com/toc/?dbmr=global-meglinitides-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best Market opportunities and foster efficient information for your business to thrive in the Market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgeMarketresearch.com
Browse Related Reports@
Ø Global Rare Disease Genetic Testing Market
Ø Global Renal Denervation Market
Ø Global Pemphigus Vulgaris Treatment Market
Ø Global Medical Necessity Management Software Market
Ø Global Healthcare Information Software Market
Ø Global Immunoprotein Diagnostic Testing Market
